The clinical guiding value of a radiomics model for androgen deprivation therapy for prostate cancer

OBJECTIVE: Three models were used to evaluate prostate cancer after androgen deprivation therapy (ADT) and to determine the value of detecting residual lesions after treatment. METHODS: We retrospectively analysed patients with prostate cancer who received ADT from January 2018 to June 2019. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Na, Wang, Baoping, Ren, Jialiang, Wu, Hui, Gao, Yang, Liu, Aishi, Niu, Guangming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258766/
https://www.ncbi.nlm.nih.gov/pubmed/34187217
http://dx.doi.org/10.1177/03000605211014301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258766/
https://www.ncbi.nlm.nih.gov/pubmed/34187217
http://dx.doi.org/10.1177/03000605211014301

Ejemplares similares